Shukra Pharmaceuticals Shareholding Pattern & Promoter Holding

Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026

As of Sep 2026, promoters hold 51.16% of Shukra Pharmaceuticals, FIIs hold 0.43%, DIIs hold 0.21% and the public holds 48.20%. Promoter holding rose by 0.21 percentage points from Jun 2026.

Get an alert when Shukra Pharmaceuticals reports results or its shareholding changes. Free account.

Promoters

51.16%

+0.21 pp QoQ

FIIs

0.43%

+0.43 pp QoQ

DIIs

0.21%

+0.10 pp QoQ

Public

48.20%

−0.73 pp QoQ

Shukra Pharmaceuticals shareholding, quarter by quarter

QuarterPromotersFIIsDIIsPublicShareholders
Sep 202651.16%0.43%0.21%48.20%35,007
Jun 202650.95%0.00%0.11%48.93%28,384
Mar 202650.95%0.00%0.11%48.92%27,173
Dec 202550.95%0.00%0.11%48.93%25,649
Sep 202550.95%0.00%0.11%48.93%21,441
Jun 202550.95%0.00%0.11%48.93%20,337
Mar 202550.95%0.00%0.11%48.93%18,231
Dec 202450.95%0.00%0.11%48.93%17,844
Sep 202450.95%0.00%0.11%48.93%16,321
Jun 202450.95%0.00%0.11%48.93%14,989
Mar 202450.95%0.00%0.11%48.93%12,974
Dec 202350.95%0.00%0.11%48.93%10,963

Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.

Value of the promoter stake

At a market capitalisation of ₹3.63k cr, the promoter group's 51.16% stake is worth ₹1.86k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.

Promoter holding in Pharmaceuticals & Biotechnology peers

Shukra Pharmaceuticals shareholding: common questions

What is the promoter holding in Shukra Pharmaceuticals?

Promoters hold 51.16% of Shukra Pharmaceuticals as of Sep 2026. Their stake rose by 0.21 percentage points from Jun 2026.

How much do FIIs hold in Shukra Pharmaceuticals?

Foreign institutional investors (FIIs) held 0.43% of Shukra Pharmaceuticals in Sep 2026, +0.43 pp versus Jun 2026.

How much do mutual funds and other DIIs hold in Shukra Pharmaceuticals?

Domestic institutional investors (DIIs), which include mutual funds and insurers, held 0.21% of Shukra Pharmaceuticals in Sep 2026, +0.10 pp versus Jun 2026.

Is the promoter holding in Shukra Pharmaceuticals pledged?

The latest disclosed shareholding pattern shows no pledged promoter shares in Shukra Pharmaceuticals.

How has Shukra Pharmaceuticals's promoter holding changed in the last year?

Promoter holding moved from 50.95% in Sep 2025 to 51.16% in Sep 2026 (+0.21 pp).

How many shareholders does Shukra Pharmaceuticals have?

Shukra Pharmaceuticals had 35,007 shareholders in Sep 2026, compared with 28,384 in Jun 2026.